000711916 000__ 03050cam\a2200457Ii\4500
000711916 001__ 711916
000711916 005__ 20230306140217.0
000711916 006__ m\\\\\o\\d\\\\\\\\
000711916 007__ cr\cn\nnnunnun
000711916 008__ 141023s2014\\\\nyua\\\\o\\\\\001\0\eng\d
000711916 020__ $$a9781493915194$$qelectronic book
000711916 020__ $$a1493915193$$qelectronic book
000711916 020__ $$z9781493915187
000711916 0247_ $$a10.1007/978-1-4939-1519-4$$2doi
000711916 035__ $$aSP(OCoLC)ocn893607908
000711916 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dN$T$$dYDXCP$$dOCLCQ$$dE7B$$dOCLCQ$$dUPM
000711916 049__ $$aISEA
000711916 050_4 $$aRS201.C64
000711916 08204 $$a615.1/9$$223
000711916 24500 $$aHydrophilic matrix tablets for oral controlled release$$h[electronic resource] /$$cPeter Timmins, Samuel R. Pygall, Colin D. Melia, editors.
000711916 264_1 $$aNew York, NY :$$bSpringer,$$c2014.
000711916 300__ $$a1 online resource (ix, 326 pages) :$$billustrations (some color).
000711916 336__ $$atext$$btxt$$2rdacontent
000711916 337__ $$acomputer$$bc$$2rdamedia
000711916 338__ $$aonline resource$$bcr$$2rdacarrier
000711916 4901_ $$aAAPS Advances in the Pharmaceutical Sciences Series,$$x2210-7371 ;$$v16
000711916 500__ $$aIncludes index.
000711916 5050_ $$a1. Hydrophilic Matrix Dosage Forms: Definitions, General Attributes and the Evolution of Clinical Utilization -- 2. Design and Evaluation of Hydroxypropyl Methylcellulose Matrix Tablets for Oral Controlled Release: a Historical Perspective -- 3. An Industrial Perspective on Hydrophilic Matrix Tablets based on Hyproxypropyl Methylcellulose (Hypromellose) -- 4. Natural Polysaccharides in Hydrophilic Matrices -- 5. Applications of Polyethylene Oxide (POLYOX) in Hydrophilic Matrices -- 6. A Formulation Development Perspective on Critical Interactions Affecting the Performance of Hydrophilic Matrix Tablets -- 7. In vitro Physical and Imaging Techniques to Evaluate Drug Release Mechanisms from Hydrophilic Matrix Tablets -- 8. Physiologically-Based Pharmacokinetic Modelling in the Development and Evaluation of Hydrophilic Matrix Tablets -- 9. Approaches to Rapid In Vivo Optimization of Hydrophilic Matrix Tablets -- 10. Extrusion: an Enabling Technology for Controlled Release Hydrophilic Matrix Systems -- 11. Microenvironmental pH Control and Mixed Polymer Approaches to Optimize Drug Delivery with Hydrophilic Matrix Tablets -- 12. Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form-Food Interactions and Dosage Form Gastrointestinal Tract Interactions.
000711916 506__ $$aAccess limited to authorized users.
000711916 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed October 13, 2014).
000711916 650_0 $$aDrugs$$xControlled release.
000711916 650_0 $$aOral medication.
000711916 650_0 $$aPharmaceutical chemistry.
000711916 7001_ $$aTimmins, Peter,$$eeditor.
000711916 7001_ $$aPygall, Samuel,$$eeditor.
000711916 7001_ $$aMelia, Colin D.,$$eeditor.
000711916 830_0 $$aAAPS advances in the pharmaceutical sciences series ;$$v16.
000711916 85280 $$bebk$$hSpringerLink
000711916 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://dx.doi.org/10.1007/978-1-4939-1519-4$$zOnline Access
000711916 909CO $$ooai:library.usi.edu:711916$$pGLOBAL_SET
000711916 980__ $$aEBOOK
000711916 980__ $$aBIB
000711916 982__ $$aEbook
000711916 983__ $$aOnline
000711916 994__ $$a92$$bISE